Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Maravai LifeSciences A | MRVI | Oct 31, 2024 | 7.41 | -2.88 |
Marblegate Acquisition A | GATE | Oct 31, 2024 | 11.19 | +0.36 |
Marchex B | MCHX | Oct 31, 2024 | 1.84 | +3.37 |
Marcus | MCS | Oct 31, 2024 | 18.87 | +9.90 |
Marcus & Millichap | MMI | Oct 31, 2024 | 37.84 | -1.94 |
Marex Group | MRX | Oct 31, 2024 | 26.34 | -0.79 |
Marin Software | MRIN | Oct 31, 2024 | 2.06 | -4.63 |
Marine Petroleum Trust U | MARPS | Oct 31, 2024 | 4.11 | +2.49 |
Marine Products | MPX | Oct 31, 2024 | 9.41 | -1.26 |
MarineMax | HZO | Oct 31, 2024 | 29.13 | -3.03 |
Marinus Pharmaceuticals | MRNS | Oct 31, 2024 | 0.30 | -5.11 |
Maris-Tech | MTEK | Oct 31, 2024 | 1.84 | -1.08 |
Markel | MKL | Oct 31, 2024 | 1 542.01 | -1.54 |
Marker Therapeutics | MRKR | Oct 31, 2024 | 4.05 | -0.49 |
Market Vectors Bdc Income ETF | BIZD | Oct 31, 2024 | 16.25 | -0.43 |
Market Vectors Investment Grade | FLTR | Oct 31, 2024 | 25.51 | 0.00 |
Market Vectors Israel ETF | ISRA | Oct 31, 2024 | 39.71 | -0.87 |
Market Vectors Preferred Securi | PFXF | Oct 31, 2024 | 17.93 | -0.88 |
MarketAxess | MKTX | Oct 31, 2024 | 289.42 | -1.43 |
MarketWise A | MKTW | Oct 31, 2024 | 0.58 | -5.68 |
Markforged | MKFG | Oct 31, 2024 | 4.40 | 0.00 |
Marpai A | MRAI | Oct 31, 2024 | 1.94 | 0.00 |
Marqeta A | MQ | Oct 31, 2024 | 5.66 | -0.18 |
Marriott International A | MAR | Oct 31, 2024 | 260.02 | -1.60 |
Marriott Vacations Worldwide | VAC | Oct 31, 2024 | 77.03 | -4.01 |
Mars Acquisition | MARX | Oct 31, 2024 | 11.08 | +0.18 |
Mars Acquisition Units | MARXU | Oct 31, 2024 | 11.21 | 0.00 |
Marsh & McLennan Companies | MMC | Oct 31, 2024 | 218.24 | -1.26 |
Marten Tranport | MRTN | Oct 31, 2024 | 15.48 | -1.34 |
Marti Technologies | MRT | Oct 31, 2024 | 1.99 | -4.78 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.